MEDICAL ADVOCATES
 IDUs
  European Harm Reduction
Programs

 Regional/Multinational
France
Ireland
Slovenia
Spain
United Kingdom




 
National Prevention Programs Main New and Noteworthy Home Page
Last Update:  July 14, 2008  
  Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
Regional/Multinational
       
        Journal Papers, Abstracts, and Commentaries
 
  Access and coverage of needle and syringe programmes (NSP) in Central and Eastern
Europe and Central Asia.
Aceijas C, Hickman M, Donoghoe MC, et al  
Addiction. 2007 Jun 12;
Abstract
France
         

        Journal Papers, Abstracts, and Commentaries

  Multiple access to sterile syringes for injection drug users: vending machines,
needle exchange programs and legal pharmacy sales in Marseille, France.
Moatti JP, Vlahov D, Feroni I, et al. 
Eur Addict Res 2001 Mar;7(1):40-5
 Abstract

         Conference Reports, Abstracts, and Posters

  Monitoring harm reduction among intravenous drug users in France, 1996-2002
J Emmanuelli
 (15IAC)
 Abstract
Ireland
         

          Journal Papers, Abstracts, and Commentaries

 
Recipient syringe sharing and its relationship to social proximity, perception of risk and
preparedness to share.
Smyth BP, Roche A.
Addict Behav. 2006 Dec 22;
 Abstract

Syringe borrowing persists in Dublin despite harm reduction interventions.
Smyth BP, Barry J,Keenan E.  
Addiction 2001 May;96(5):717-27
 Abstract
Slovenia
       
         Conference Reports, Abstracts, and Posters
 
  Obstacles in maintenance the harm reduction program for injection drug
users in Slovenia
EL Leskovsek
 (15IAC)
 Abstract
Spain
         

          Journal Papers, Abstracts, and Commentaries

  Community collection of syringes by parenteral drug users complementary to syringe
exchange programs  
Bechich S, Martinez M, Llorella G, et al.  
Gac Sanit 2001 Jul;15(4):353-355
 Abstract
United Kingdom
         

          Journal Papers, Abstracts, and Commentaries

 
The Fine Line between Harm Reduction and Harm Production - Development of a Clinical Policy on
Femoral (Groin) Injecting.
Zador D, Lintzeris N, van der Waal R, er al 
Eur Addict Res. 2008 Jun 27;14(4):213-218.
 Abstract
 
FULL-TEXT PDF ARTICLE
The impact of citrate introduction at UK syringe exchange programmes: a retrospective cohort
study in Cheshire and Merseyside, UK.
Beynon CM, McVeigh J, Chandler M, et al 
Harm Reduct J. 2007 Dec 11;4(1):21
Paper
 
Model Projections on the Required Coverage of Syringe Distribution to Prevent HIV Epidemics
Among Injecting Drug Users.
Vickerman P, Hickman M, Rhodes T, Watts C.
J Acquir Immune Defic Syndr. 2006 Apr 24;
Abstract
 
Impact of a medically supervised safer injection facility on community drug use patterns:
a before and after study
Ker T, Stoltz J-A, Mark Tyndall P, et al
BMJ 2006;332:220-222,
Abstract
 
FULL-TEXT ARTICLE
 A review of HIV prevention among young injecting drug users: A guide for researchers.
Dolan KA, Niven H. 
Harm Reduct J. 2005 Mar 17;2(1):5
PDF Paper

Guidelines for the control of hepatitis A virus infection  .
Crowcroft NS, Walsh B, Davison KL, Gungabissoon U; PHLS Advisory Committee on
Vaccination and Immunisation.
Commun Dis Public Health 2001 Sep;4(3):213-27
 Abstract
   
  Reduced injection risk and sexual risk behaviours after drug misuse treatment: results
from the National Treatment Outcome Research Study.
Gossop M, Marsden J, Stewart D, Treacy S. 
AIDS Care 2002 Feb;14(1):77-93
 Abstract
 

National Prevention Programs Main New and Noteworthy Home Page

European IDU Infectious Disease Prevention/Reduction Programs